Source: Annual Congress 2005 - Paediatric asthma drug therapy
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Breborowicz, M. Niedziela (Poznan, Poland). Low risk of adrenal dysfunction in children with severe asthma treated with high-dose inhaled glucocorticoids. Eur Respir J 2005; 26: Suppl. 49, 1058

Member's Comments

No comment yet.

Related content which might interest you: The use of inhaled corticosteroids and the risk of adrenal insufficiency Source: Eur Respir J 2013; 42: 79-86 Year: 2013 Adrenal function with low acth doses in asthmatic children with inhaled corticosteroids Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Children with mild asthma: do they benefit from inhaled corticosteroids? Source: Eur Respir J 2002; 20: 1470-1475 Year: 2002 Adrenal suppression in children using inhaled corticosteroids: neither recommended nor presribed doses identify those at risk Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma Year: 2004 Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids Source: Breathe 2010; 6: 365 Year: 2010 Laryngeal dysfunction is predominant in asthmatic women treated by inhaled corticosteroids Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Patients with moderate asthma symptoms may benefit from short-term inhaled corticosteroid monotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 615s Year: 2007 Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma Source: Eur Respir J 2003; 21: 633-636 Year: 2003 Adrenal insufficiency in asthma treated with high/low systemic corticosteroids in the past and in those who sucessfully discontinued systemic corticosteroids after treatment with omalizmab. Source: International Congress 2017 – Management of asthma in different situations Year: 2017 Low-dose inhaled and nasal corticosteroid use and the risk of cataracts Source: Eur Respir J 2006; 27: 1168-1174 Year: 2006 Adding slow-released theophyllne to inhaled corticosteroids in the treatment of mild persistent asthma Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma Year: 2007 The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Adrenal function improvement of most asthmatic children on inhaled corticosteroids Source: Eur Respir J 2006; 28: Suppl. 50, 260s Year: 2006 A low-dose (1.0 mcg) rapid ACTH test and adrenal function in adult patients with bronchial asthma treated with inhaled corticosteroids Source: Eur Respir J 2007; 30: Suppl. 51, 69s Year: 2007 Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004 Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of IL13 with asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids Source: Eur Respir J 2001; 17: 337-342 Year: 2001 The effect of high dose bronchodilators on cardiac function in elderly people with severe COPD or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002